MedTrace Logo

Neuropsychological Patterns of Suicide Ideators and Suicide Attempters

NCT06248268 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2026-01-16

No results posted yet for this study

Summary

The present study consists of 3 projects in total and aims to investigate the (neuro-) psychological patterns from suicidal ideation to suicidal behavior as well as the effects and feasibility of ASSIP Home Treatment.

The overall aim of project 1 is to determine (neuro-) psychological differences between suicide attempters, suicide ideators, a clinical control group, and healthy controls. Study participants in project 1 will participate in a one-time (neuro-) psychological assessment.

Project 1 of this study is an observational cross-sectional study with four groups that will be conducted at the University Hospital of Psychiatry and Psychotherapy Bern (Switzerland): Patients with at least one suicide attempt in their past (SUAT), patients with suicidal ideation (SUID), patients from the same clinical cohort, without neither suicidal behavior or ideation (CLIN) and the healthy group (HLTH). The cohorts to be examined (SUAT \& SUID) will be compared to the two control groups (CLIN \& HLTH). Only people who have signed the informed consent and meet the eligibility criteria can participate in this study.

Conditions

  • Inhibitory Control
  • Locus of Control
  • Self Efficacy
  • Suicide, Attempted
  • Suicidal Ideation
  • Attention

Interventions

OTHER

(Neuro-)psychological assessment

The measurement, which takes place 1 week after the informed consent, aims to determine the distinct (neuro-) psychological patterns of suicidal behavior versus suicidal ideation, in comparison to two control groups.

Sponsors & Collaborators

  • University of Bern

    lead OTHER

Principal Investigators

  • Anja C. Gysin-Maillart, PD Dr. phil. · University of Bern, University Hospital of Psychiatry, Translational Research Center

  • Lara M. Aschenbrenner, M.Sc. · University of Bern, University Hospital of Psychiatry, Translational Research Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-08
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06248268 on ClinicalTrials.gov